nach oben

Basic Research in Cardiology

Erschienen in:

01.03.2013 | Original Contribution

Novel effects of adenosine receptors on pericellular hyaluronan matrix: implications for human smooth muscle cell phenotype and interactions with monocytes during atherosclerosis

verfasst von: M. Grandoch, J. Hoffmann, K. Röck, F. Wenzel, A. Oberhuber, H. Schelzig, J. W. Fischer

Erschienen in: Basic Research in Cardiology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Hyaluronan (HA) is responsive to pro-atherosclerotic growth factors and cytokines and is thought to contribute to neointimal hyperplasia and atherosclerosis. However, the specific function of the pericellular HA matrix is likely depend on the respective stimuli. Adenosine plays an important role in the phenotypic regulation of vascular smooth muscle cells (VSMC) and is thought to inhibit inflammatory responses during atherosclerosis. The aim of this study was to examine the regulation and function of HA matrix in response to adenosine in human coronary artery SMC (HCASMC). The adenosine receptor agonist NECA (10 μM) caused a strong induction of HA synthase (HAS)1 at 6 h and a weaker induction again after 24 h. Use of selective adenosine receptor antagonists revealed that adenosine A2_B receptors (A2_BR) mediate the early HAS1 induction, whereas late HAS1 induction was mediated via A2_AR and A3R. The strong response after 6 h was mediated in part via phosphoinositide-3 kinase- and mitogen-activated protein kinase pathways and was inhibited by Epac. Functionally, NECA increased cell migration, which was abolished by shRNA-mediated knock down of HAS1. In addition to HA secretion, NECA also stimulated the formation of pronounced pericellular HA matrix in HCASMC and increased the adhesion of monocytes. The adenosine-induced monocyte adhesion was sensitive to hyaluronidase. In conclusion, the current data suggest that adenosine via adenosine A2_BR and A2_AR/A3R induces HAS1. In turn a HA-rich matrix is formed by HCASMC which likely supports the migratory HCASMC phenotype and traps monocytes/macrophages in the interstitial matrix.

Baharav E, Bar-Yehuda S, Madi L, Silberman D, Rath-Wolfson L, Halpren M, Ochaion A, Weinberger A, Fishman P (2005) Antiinflammatory effect of a3 adenosine receptor agonists in murine autoimmune arthritis models. J Rheumatol 32:469–476PubMed

Buchheiser A, Ebner A, Burghoff S, Ding Z, Romio M, Viethen C, Lindecke A, Kohrer K, Fischer JW, Schrader J (2011) Inactivation of cd73 promotes atherogenesis in apolipoprotein e-deficient mice. Cardiovasc Res 92:338–347. doi:10.1093/cvr/cvr218 PubMedCrossRef

Campo GM, Avenoso A, D’Ascola A, Prestipino V, Scuruchi M, Nastasi G, Calatroni A, Campo S (2012) The stimulation of adenosine 2a receptor reduces inflammatory response in mouse articular chondrocytes treated with hyaluronan oligosaccharides. Matrix Biol 31:338–351. doi:10.1016/j.matbio.2012.07.001 PubMedCrossRef

Campo GM, Avenoso A, D’Ascola A, Scuruchi M, Prestipino V, Nastasi G, Calatroni A, Campo S (2012) Adenosine a2a receptor activation and hyaluronan fragment inhibition reduce inflammation in mouse articular chondrocytes stimulated with interleukin-1beta. FEBS J 279:2120–2133. doi:10.1111/j.1742-4658.2012.08598.x PubMedCrossRef

Ceruti S, Franceschi C, Barbieri D, Malorni W, Camurri A, Giammarioli AM, Ambrosini A, Racagni G, Cattabeni F, Abbracchio MP (2000) Apoptosis induced by 2-chloro-adenosine and 2-chloro-2′-deoxy-adenosine in a human astrocytoma cell line: differential mechanisms and possible clinical relevance. J Neurosci Res 60:388–400. doi:10.1002/(SICI)1097-4547(20000501)60:3<388:AID-JNR14>3.0.CO;2-V PubMedCrossRef

Ceruti S, Giammarioli AM, Camurri A, Falzano L, Rufini S, Frank C, Fiorentini C, Malorni W, Abbracchio MP (2000) Adenosine- and 2-chloro-adenosine-induced cytopathic effects on myoblastic cells and myotubes: involvement of different intracellular mechanisms. Neuromuscul Disord 10:436–446. doi:10.1016/S0960-8966(00)00118-8 PubMedCrossRef

Chajara A, Raoudi M, Delpech B, Leroy M, Basuyau JP, Levesque H (2000) Increased hyaluronan and hyaluronidase production and hyaluronan degradation in injured aorta of insulin-resistant rats. Arterioscler Thromb Vasc Biol 20:1480–1487. doi:10.1161/01.ATV.20.6.1480 PubMedCrossRef

Clarke MC, Figg N, Maguire JJ, Davenport AP, Goddard M, Littlewood TD, Bennett MR (2006) Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 12:1075–1080. doi:10.1038/nm1459 PubMedCrossRef

Dai G, Freudenberger T, Zipper P, Melchior A, Grether-Beck S, Rabausch B, de Groot J, Twarock S, Hanenberg H, Homey B, Krutmann J, Reifenberger J, Fischer JW (2007) Chronic ultraviolet b irradiation causes loss of hyaluronic acid from mouse dermis because of down-regulation of hyaluronic acid synthases. Am J Pathol 171:1451–1461. doi:10.2353/ajpath.2007.070136 PubMedCrossRef

10.

de la Motte CA, Hascall VC, Drazba J, Bandyopadhyay SK, Strong SA (2003) Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid: polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol 163:121–133. doi:10.1016/S0002-9440(10)63636-X PubMedCrossRef

11.

Dubey RK, Gillespie DG, Mi Z, Jackson EK (1998) Adenosine inhibits growth of human aortic smooth muscle cells via a2b receptors. Hypertension 31:516–521. doi:10.1161/01.HYP.31.1.516 PubMedCrossRef

12.

Dubey RK, Gillespie DG, Mi Z, Suzuki F, Jackson EK (1996) Smooth muscle cell-derived adenosine inhibits cell growth. Hypertension 27:766–773. doi:10.1161/01.HYP.27.3.766 PubMedCrossRef

13.

Dubey RK, Gillespie DG, Shue H, Jackson EK (2000) A(2b) receptors mediate antimitogenesis in vascular smooth muscle cells. Hypertension 35:267–272. doi:10.1161/01.HYP.35.1.267 PubMedCrossRef

14.

Ellenbogen KA, O’Neill G, Prystowsky EN, Camm JA, Meng L, Lieu HD, Jerling M, Shreeniwas R, Belardinelli L, Wolff AA (2005) Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson. Circulation 111:3202–3208. doi:10.1161/CIRCULATIONAHA.104.510982 PubMedCrossRef

15.

Evanko SP, Angello JC, Wight TN (1999) Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19:1004–1013. doi:10.1161/01.ATV.19.4.1004 PubMedCrossRef

16.

Evanko SP, Potter-Perigo S, Bollyky PL, Nepom GT, Wight TN (2012) Hyaluronan and versican in the control of human t-lymphocyte adhesion and migration. Matrix Biol 31:90–100. doi:10.1016/j.matbio.2011.10.004 PubMedCrossRef

17.

Fang Y, Olah ME (2007) Cyclic amp-dependent, protein kinase a-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by camp 1 (epac1). J Pharmacol Exp Ther 322:1189–1200. doi:10.1124/jpet.107.119933 PubMedCrossRef

18.

Fossetta J, Jackson J, Deno G, Fan X, Du XK, Bober L, Soude-Bermejo A, de Bouteiller O, Caux C, Lunn C, Lundell D, Palmer RK (2003) Pharmacological analysis of calcium responses mediated by the human a3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells. Mol Pharmacol 63:342–350. doi:10.1124/mol.63.2.342 PubMedCrossRef

19.

Fredholm BB (2007) Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 14:1315–1323. doi:10.1038/sj.cdd.4402132 PubMedCrossRef

20.

Freudenberger T, Rock K, Dai G, Dorn S, Mayer P, Heim HK, Fischer JW (2011) Estradiol inhibits hyaluronic acid synthase 1 expression in human vascular smooth muscle cells. Basic Res Cardiol 106:1099–1109. doi:10.1007/s00395-011-0217-5 PubMedCrossRef

21.

Hashikawa T, Takedachi M, Terakura M, Yamada S, Thompson LF, Shimabukuro Y, Murakami S (2006) Activation of adenosine receptor on gingival fibroblasts. J Dent Res 85:739–744. doi:10.1177/154405910608500810 PubMedCrossRef

22.

Heusch G (2010) Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve. Basic Res Cardiol 105:1–5. doi:10.1007/s00395-009-0074-7 PubMedCrossRef

23.

Itano N, Kimata K (2002) Mammalian hyaluronan synthases. IUBMB Life 54:195–199. doi:10.1080/15216540214929 PubMedCrossRef

24.

Jackson EK, Ren J, Gillespie DG, Dubey RK (2010) Extracellular 2′,3′-cyclic adenosine 5′-monophosphate is a potent inhibitor of preglomerular vascular smooth muscle cell and mesangial cell growth. Hypertension 56:151–158. doi:10.1161/HYPERTENSIONAHA.110.152454 PubMedCrossRef

25.

Jacobson KA, Gao ZG (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5:247–264. doi:10.1038/nrd1983 PubMedCrossRef

26.

Jones MR, Zhao Z, Sullivan CP, Schreiber BM, Stone PJ, Toselli PA, Kagan HM, Cohen RA, Ravid K (2004) A(3) adenosine receptor deficiency does not influence atherogenesis. J Cell Biochem 92:1034–1043. doi:10.1002/jcb.20122 PubMedCrossRef

27.

Kleinbongard P, Bose D, Baars T, Mohlenkamp S, Konorza T, Schoner S, Elter-Schulz M, Eggebrecht H, Degen H, Haude M, Levkau B, Schulz R, Erbel R, Heusch G (2011) Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. Circ Res 108:344–352. doi:10.1161/CIRCRESAHA.110.235713 PubMedCrossRef

28.

Kolodgie FD, Burke AP, Farb A, Weber DK, Kutys R, Wight TN, Virmani R (2002) Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol 22:1642–1648. doi:10.1161/01.ATV.0000034021.92658.4C PubMedCrossRef

29.

Koyama N, Harada K, Yamamoto A, Morisaki N, Saito Y, Yoshida S (1993) Purification and characterization of an autocrine migration factor for vascular smooth muscle cells (smc), smc-derived migration factor. J Biol Chem 268:13301–13308PubMed

30.

Levesque H, Girard N, Maingonnat C, Delpech A, Chauzy C, Tayot J, Courtois H, Delpech B (1994) Localization and solubilization of hyaluronan and of the hyaluronan-binding protein hyaluronectin in human normal and arteriosclerotic arterial walls. Atherosclerosis 105:51–62. doi:10.1016/0021-9150(94)90007-8 PubMedCrossRef

31.

Lukashev D, Ohta A, Sitkovsky M (2004) Targeting hypoxia–a(2a) adenosine receptor-mediated mechanisms of tissue protection. Drug Discov Today 9:403–409. doi:10.1016/S1359-6446(04)03044-2 PubMedCrossRef

32.

Mayer P, Hinze AV, Harst A, von Kugelgen I (2011) A(2)b receptors mediate the induction of early genes and inhibition of arterial smooth muscle cell proliferation via epac. Cardiovasc Res 90:148–156. doi:10.1093/cvr/cvq371 PubMedCrossRef

33.

Murakami S, Hashikawa T, Saho T, Takedachi M, Nozaki T, Shimabukuro Y, Okada H (2001) Adenosine regulates the il-1 beta-induced cellular functions of human gingival fibroblasts. Int Immunol 13:1533–1540. doi:10.1093/intimm/13.12.1533 PubMedCrossRef

34.

Nagy N, Freudenberger T, Melchior-Becker A, Rock K, Ter Braak M, Jastrow H, Kinzig M, Lucke S, Suvorava T, Kojda G, Weber AA, Sorgel F, Levkau B, Ergun S, Fischer JW (2010) Inhibition of hyaluronan synthesis accelerates murine atherosclerosis: novel insights into the role of hyaluronan synthesis. Circulation 122:2313–2322. doi:10.1161/CIRCULATIONAHA.110.972653 PubMedCrossRef

35.

Odashima M, Bamias G, Rivera-Nieves J, Linden J, Nast CC, Moskaluk CA, Marini M, Sugawara K, Kozaiwa K, Otaka M, Watanabe S, Cominelli F (2005) Activation of a2a adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 129:26–33. doi:10.1053/j.gastro.2005.05.032 PubMedCrossRef

36.

Ohta A, Sitkovsky M (2001) Role of g-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414:916–920. doi:10.1038/414916a PubMedCrossRef

37.

Okusa MD, Linden J, Huang L, Rieger JM, Macdonald TL, Huynh LP (2000) A(2a) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol 279:F809–F818PubMed

38.

Papakonstantinou E, Roth M, Block LH, Mirtsou-Fidani V, Argiriadis P, Karakiulakis G (1998) The differential distribution of hyaluronic acid in the layers of human atheromatic aortas is associated with vascular smooth muscle cell proliferation and migration. Atherosclerosis 138:79–89. doi:10.1016/S0021-9150(98)00006-9 PubMedCrossRef

39.

Peirce SM, Skalak TC, Rieger JM, Macdonald TL, Linden J (2001) Selective a(2a) adenosine receptor activation reduces skin pressure ulcer formation and inflammation. Am J Physiol Heart Circ Physiol 281:H67–H74PubMed

40.

Potter-Perigo S, Johnson PY, Evanko SP, Chan CK, Braun KR, Wilkinson TS, Altman LC, Wight TN (2010) Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion. Am J Respir Cell Mol Biol 43:109–120. doi:10.1165/rcmb.2009-0081OC PubMedCrossRef

41.

Riessen R, Wight TN, Pastore C, Henley C, Isner JM (1996) Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 93:1141–1147. doi:10.1161/01.CIR.93.6.1141 PubMedCrossRef

42.

Scheibner KA, Boodoo S, Collins S, Black KE, Chan-Li Y, Zarek P, Powell JD, Horton MR (2009) The adenosine a2a receptor inhibits matrix-induced inflammation in a novel fashion. Am J Respir Cell Mol Biol 40:251–259. doi:10.1165/rcmb.2008-0168OC PubMedCrossRef

43.

Schulte G, Sommerschild H, Yang J, Tokuno S, Goiny M, Lovdahl C, Johansson B, Fredholm BB, Valen G (2004) Adenosine a receptors are necessary for protection of the murine heart by remote, delayed adaptation to ischaemia. Acta Physiol Scand 182:133–143. doi:10.1111/j.1365-201X.2004.01350.x PubMedCrossRef

44.

Shen J, Halenda SP, Sturek M, Wilden PA (2005) Novel mitogenic effect of adenosine on coronary artery smooth muscle cells: role for the a1 adenosine receptor. Circ Res 96:982–990. doi:10.1161/01.RES.0000165800.81876.52 PubMedCrossRef

45.

Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, Caldwell C, Ohta A, Thiel M (2004) Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine a2a receptors. Annu Rev Immunol 22:657–682. doi:10.1146/annurev.immunol.22.012703.104731 PubMedCrossRef

46.

Toole BP (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4:528–539. doi:10.1038/nrc1391 PubMedCrossRef

47.

Vigetti D, Viola M, Karousou E, Rizzi M, Moretto P, Genasetti A, Clerici M, Hascall VC, De Luca G, Passi A (2008) Hyaluronan-cd44-erk1/2 regulate human aortic smooth muscle cell motility during aging. J Biol Chem 283:4448–4458. doi:10.1074/jbc.M709051200 PubMedCrossRef

48.

Wang A, Hascall VC (2004) Hyaluronan structures synthesized by rat mesangial cells in response to hyperglycemia induce monocyte adhesion. J Biol Chem 279:10279–10285. doi:10.1074/jbc.M312045200 PubMedCrossRef

49.

Wang H, Zhang W, Tang R, Zhu C, Bucher C, Blazar BR, Geng JG, Zhang C, Linden J, Wu C, Huo Y (2010) Adenosine receptor a2a deficiency in leukocytes increases arterial neointima formation in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 30:915–922. doi:10.1161/ATVBAHA.109.202572 PubMedCrossRef

50.

Wang H, Zhang W, Zhu C, Bucher C, Blazar BR, Zhang C, Chen JF, Linden J, Wu C, Huo Y (2009) Inactivation of the adenosine a2a receptor protects apolipoprotein e-deficient mice from atherosclerosis. Arterioscler Thromb Vasc Biol 29:1046–1052. doi:10.1161/ATVBAHA.109.188839 PubMedCrossRef

51.

Wight TN (2008) Arterial remodeling in vascular disease: a key role for hyaluronan and versican. Front Biosci 13:4933–4937. doi:10.2741/3052 PubMedCrossRef

52.

Wilkinson TS, Bressler SL, Evanko SP, Braun KR, Wight TN (2006) Overexpression of hyaluronan synthases alters vascular smooth muscle cell phenotype and promotes monocyte adhesion. J Cell Physiol 206:378–385. doi:10.1002/jcp.20468 PubMedCrossRef

53.

Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K (2006) The a2b adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 116:1913–1923. doi:10.1172/JCI27933 PubMedCrossRef

54.

Yang Z, Cerniway RJ, Byford AM, Berr SS, French BA, Matherne GP (2002) Cardiac overexpression of a1-adenosine receptor protects intact mice against myocardial infarction. Am J Physiol Heart Circ Physiol 282:H949–H955. doi:10.1152/ajpheart.00741.2001 PubMed

55.

Zablocki JA, Wu L, Shryock J, Belardinelli L (2004) Partial a(1) adenosine receptor agonists from a molecular perspective and their potential use as chronic ventricular rate control agents during atrial fibrillation (af). Curr Top Med Chem 4:839–854PubMedCrossRef

Titel: Novel effects of adenosine receptors on pericellular hyaluronan matrix: implications for human smooth muscle cell phenotype and interactions with monocytes during atherosclerosis
verfasst von: M. Grandoch
J. Hoffmann
K. Röck
F. Wenzel
A. Oberhuber
H. Schelzig
J. W. Fischer
Publikationsdatum: 01.03.2013
Verlag: Springer-Verlag
Erschienen in: Basic Research in Cardiology / Ausgabe 2/2013
Print ISSN: 0300-8428
Elektronische ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-013-0340-6

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2013

Endothelial NOS (NOS3) impairs myocardial function in developing sepsis

Deletion of Fn14 receptor protects from right heart fibrosis and dysfunction

Islet1 is a direct transcriptional target of the homeodomain transcription factor Shox2 and rescues the Shox2-mediated bradycardia

Erratum to: Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo